{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T01:32:17Z","timestamp":1768267937274,"version":"3.49.0"},"reference-count":96,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1097\/01.bor.0000198002.42826.c2","type":"journal-article","created":{"date-parts":[[2005,12,12]],"date-time":"2005-12-12T09:01:29Z","timestamp":1134378089000},"page":"54-63","source":"Crossref","is-referenced-by-count":156,"title":["Cryoglobulinemic vasculitis"],"prefix":"10.1097","volume":"18","author":[{"given":"Clodoveo","family":"Ferri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Teresa","family":"Mascia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-10-20210128","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/0002-9343(66)90200-2","article-title":"Cryoglobulinemia: a clinical and laboratory study. II: Cryoglobulins with rheumatoid factor activity","volume":"40","author":"Meltzer","year":"1966","journal-title":"Am J Med"},{"key":"R2-10-20210128","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/0002-9343(74)90852-3","article-title":"Biologic and clinical significance of cryoglobulins","volume":"57","author":"Brouet","year":"1974","journal-title":"Am J Med"},{"key":"R3-10-20210128","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0002-9343(80)90390-3","article-title":"Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients","volume":"69","author":"Gorevic","year":"1980","journal-title":"Am J Med"},{"key":"R4-10-20210128","first-page":"79","article-title":"Mixed cryoglobulinemia cross-reactive idiotypes: implication for relationship of MC to rheumatic and lymphoproliferative diseases","volume":"28","author":"Gorevic","year":"1991","journal-title":"Semin Hematol"},{"key":"R5-10-20210128","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1136\/jcp.55.1.4","article-title":"Cryoglobulins","volume":"55","author":"Ferri","year":"2002","journal-title":"J Clin Pathol"},{"key":"R7-10-20210128","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1046\/j.1365-2362.2001.00824.x","article-title":"The cryoglobulins: an overview","volume":"31","author":"Dammacco","year":"2001","journal-title":"Eur J Clin Invest"},{"key":"R8-10-20210128","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/BF02909351","article-title":"Cryoglobulins and immune complexes in essential mixed cryoglobulinemia","volume":"16","author":"Bombardieri","year":"1986","journal-title":"La Ricerca Clin Lab"},{"key":"R9-10-20210128","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1002\/art.1780361003","article-title":"Hepatitis C virus infection in type II mixed cryoglobulinemia","volume":"36","author":"Abel","year":"1993","journal-title":"Arthritis Rheum"},{"key":"R10-10-20210128","first-page":"115","article-title":"Cryoglobulinaemias: a multi-centre study of the early clinical and laboratory manifestations of primary and secondary disease","volume":"88","author":"Monti","year":"1995","journal-title":"QJM"},{"key":"R11-10-20210128","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.semarthrit.2003.10.001","article-title":"Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients","volume":"33","author":"Ferri","year":"2004","journal-title":"Semin Arthritis Rheum"},{"key":"R12-10-20210128","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/BF02904572","article-title":"Liver involvement in essential mixed cryoglobulinemia","volume":"9","author":"Bombardieri","year":"1979","journal-title":"La Ricerca Clin Lab"},{"key":"R13-10-20210128","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1056\/NEJM197706302962605","article-title":"Association between hepatitis B virus and essential mixed cryoglobulinemia","volume":"296","author":"Levo","year":"1977","journal-title":"N Engl J Med"},{"key":"R14-10-20210128","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1126\/science.2523562","article-title":"Isolation of a cDNA clone derived from a blood-borne non-A non-B viral hepatitis genome","volume":"244","author":"Choo","year":"1989","journal-title":"Science"},{"key":"R15-10-20210128","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1365-2362.1993.tb00782.x","article-title":"Hepatitis C virus and mixed cryoglobulinemia","volume":"23","author":"Ferri","year":"1993","journal-title":"Eur J Clin Invest"},{"key":"R16-10-20210128","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/00002281-200001000-00009","article-title":"Relation between infection and autoimmunity in mixed cryoglobulinemia","volume":"12","author":"Ferri","year":"2000","journal-title":"Curr Opin Rheumatol"},{"key":"R17-10-20210128","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1182\/blood.V82.12.3701.3701","article-title":"Infection of peripheral blood mononuclear cells by hepatitis C virus in mixed cryoglobulinemia","volume":"82","author":"Ferri","year":"1993","journal-title":"Blood"},{"key":"R18-10-20210128","first-page":"447","article-title":"Extrahepatic manifestations in patients with chronic hepatitis C virus infection","volume":"17","author":"Ramos-Casals","year":"2005","journal-title":"Curr Opin Rheumatol"},{"key":"R19-10-20210128","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jhep.2003.10.009","article-title":"Extrahepatic disease manifestations of HCV infection: some current issues","volume":"40","author":"Agnello","year":"2004","journal-title":"J Hepatol"},{"key":"R20-10-20210128","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1093\/rheumatology\/keh668","article-title":"Rheumatological manifestations of hepatitis C: incidence in a rheumatology and non-rheumatology setting and the effect of methotrexate and interferon","volume":"44","author":"Nissen","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"R21-10-20210128","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/0016-5085(94)90022-1","article-title":"Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage","volume":"106","author":"Lunel","year":"1994","journal-title":"Gastroenterology"},{"key":"R22-10-20210128","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/hep.1840190407","article-title":"Immunological disorders in C virus chronic active hepatitis: a prospective case\u2013control study","volume":"19","author":"Pawlotsky","year":"1994","journal-title":"Hepatology"},{"key":"R23-10-20210128","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1053\/jhep.2002.35620","article-title":"Hepatitis C, cryoglobulinemia, and cirrhosis: a meta-analysis","volume":"36","author":"Kayali","year":"2002","journal-title":"Hepatology"},{"key":"R24-10-20210128","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0140-6736(91)90418-O","article-title":"Antibodies to hepatitis C virus in autoimmune liver disease: evidence for geographical heterogeneity.","volume":"338ii","author":"Lenzi","year":"1991","journal-title":"Lancet"},{"key":"R25-10-20210128","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0168-8278(98)80054-8","article-title":"A clinical and virological study of hepatitis C virus-related cryoglobulinemia in Germany","volume":"29","author":"Weiner","year":"1998","journal-title":"Hepatology"},{"key":"R26-10-20210128","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00277-004-0955-7","article-title":"Life-threatening cryoglobulinemia in HCV-negative Southern Chinese and a novel association with structural aortic abnormalities","volume":"84","author":"Au","year":"2005","journal-title":"Ann Hematol"},{"key":"R27-10-20210128","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1182\/blood.V91.6.2062","article-title":"Haplotype HLA-B8-DR3 confers susceptibility to hepatitis C virus-related mixed cryoglobulinemia","volume":"91","author":"Lenzi","year":"1998","journal-title":"Blood"},{"key":"R28-10-20210128","first-page":"91","article-title":"HLA expression in type II mixed cryoglobulinemia and chronic hepatitis C virus","volume":"13","author":"Ossi","year":"1995","journal-title":"Clin Exp Rheumatol"},{"key":"R29-10-20210128","doi-asserted-by":"crossref","first-page":"31","DOI":"10.7326\/0003-4819-124-1_Part_1-199601010-00006","article-title":"Hepatitis C virus genotype analysis in patients with type II mixed cryoglobulinemia","volume":"124","author":"Zignego","year":"1996","journal-title":"Ann Intern Med"},{"key":"R30-10-20210128","doi-asserted-by":"crossref","first-page":"9145","DOI":"10.1128\/JVI.79.14.9145-9156.2005","article-title":"Compartmentalization of hepatitis C virus quasispecies in blood mononuclear cells of patients with mixed cryoglobulinemic syndrome","volume":"79","author":"Zehender","year":"2005","journal-title":"Virology"},{"issue":"Suppl 32","key":"R31-10-20210128","first-page":"S101","article-title":"Study of host and virological factors of patients with chronic HCV infection and associated laboratory or clinical autoimmune manifestations","volume":"21","author":"Vassilopoulos","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"R32-10-20210128","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1182\/blood.V91.7.2433","article-title":"Somatic hypermutation, clonal diversity, and preferential expression of the VH 51p1\/VL kv325 immunoglobulin gene combination in hepatitis C virus-associated immunocytomas","volume":"91","author":"Ivanovski","year":"1998","journal-title":"Blood"},{"key":"R33-10-20210128","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jhep.2004.11.034","article-title":"Vascular cell adhesion molecule-1 (VCAM-1) plays a central role in the pathogenesis of severe forms of vasculitis due to hepatitis C-associated mixed cryoglobulinemia","volume":"42","author":"Kaplanski","year":"2005","journal-title":"J Hepatol"},{"issue":"Suppl iii","key":"R34-10-20210128","first-page":"263","article-title":"Fibronectin gene polymorphisms influence type ii mixed cryoglobulinemia clinical manifestations [abstract]","volume":"64","author":"Fabris","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"R35-10-20210128","doi-asserted-by":"crossref","first-page":"30711","DOI":"10.1074\/jbc.M209623200","article-title":"Hepatitis C virus NS5A protein modulates c-Jun N-terminal kinase through interaction with TNF receptor-associated factor 2","volume":"278","author":"Park","year":"2003","journal-title":"J Biol Chem"},{"key":"R36-10-20210128","doi-asserted-by":"crossref","first-page":"28562","DOI":"10.1074\/jbc.M210485200","article-title":"Hepatitis C virus core protein differently regulates the JAK-STAT signaling pathway under interleukin-6 and interferon-gamma stimuli","volume":"278","author":"Hosui","year":"2003","journal-title":"J Biol Chem"},{"key":"R37-10-20210128","doi-asserted-by":"crossref","first-page":"571","DOI":"10.7326\/0003-4819-137-7-200210010-00008","article-title":"Prevalence of BCL-2 rearrangement in hepatitis C virus-related mixed cryoglobulinemia with or without complicating B-cell lymphoma","volume":"137","author":"Zignego","year":"2002","journal-title":"Ann Intern Med"},{"key":"R38-10-20210128","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1126\/science.282.5390.938","article-title":"Binding of hepatitis C virus to CD81","volume":"282","author":"Pileri","year":"1998","journal-title":"Science"},{"key":"R39-10-20210128","doi-asserted-by":"crossref","first-page":"4262","DOI":"10.1073\/pnas.0303971101","article-title":"Hepatitis C virus induces a mutator phenotype: enhanced mutations of immunoglobulin and protooncogenes","volume":"23","author":"Machida","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R40-10-20210128","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/qjmed\/hch088","article-title":"Thyroid involvement in patients with overt HCV-related mixed cryoglobulinaemia","volume":"97","author":"Antonelli","year":"2004","journal-title":"QJM"},{"issue":"Suppl III","key":"R41-10-20210128","first-page":"272","article-title":"Thyroid involvement in HCV-related cryoglobulinemic vasculitis","volume":"64","author":"Ferri","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"R42-10-20210128","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/ijc.20440","article-title":"Prospective study of transfusion history and thyroid cancer incidence among females in Japan","volume":"20","author":"Fujino","year":"2004","journal-title":"Int J Cancer"},{"key":"R43-10-20210128","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/hep.20608","article-title":"Non-Hodgkin's lymphoma and other nonhepatic malignancies in Swedish patients with hepatitis C virus infection","volume":"41","author":"Duberg","year":"2005","journal-title":"Hepatology"},{"key":"R44-10-20210128","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1093\/rheumatology\/41.3.290","article-title":"Characteristics and outcome of 49 patients with symptomatic cryoglobulinaemia","volume":"41","author":"Rieu","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"R45-10-20210128","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1002\/1529-0131(199912)42:12<2507::AID-ANR2>3.0.CO;2-#","article-title":"Cryoglobulinemic vasculitis","volume":"42","author":"Lamprecht","year":"1999","journal-title":"Arthritis Rheum"},{"key":"R47-10-20210128","first-page":"92","article-title":"Relapsing viral hepatitis type A complicated with renal failure","volume":"24","author":"Tagle","year":"2004","journal-title":"Rev Gastroenterol Peru"},{"key":"R48-10-20210128","first-page":"252","article-title":"Cryoglobulinemic vasculitis and lymphocytic interstitial pneumonitis in a person with HIV infection","volume":"15","author":"Castillo","year":"2005","journal-title":"AIDS Read"},{"key":"R49-10-20210128","first-page":"481","article-title":"Cryoglobulinemia vasculitis following intravesical instillations of bacillus Calmette-Guerin","volume":"22","author":"Granel","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"R50-10-20210128","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/00005792-200107000-00004","article-title":"Cryoglobulinemia: study of etiologic factors and clinical and immunologic features in 443 patients from a single center","volume":"80","author":"Trejo","year":"2001","journal-title":"Medicine (Baltimore)"},{"key":"R51-10-20210128","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1046\/j.1365-2893.2003.00462.x","article-title":"Occult hepatitis C virus infection in type II mixed cryoglobulinaemia","volume":"10","author":"Casato","year":"2003","journal-title":"J Viral Hepat"},{"key":"R52-10-20210128","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1086\/380202","article-title":"Occult hepatitis C virus infection in patients in whom the etiology of persistently abnormal results of liver function tests is unknown","volume":"189","author":"Castillo","year":"2004","journal-title":"J Infect Dis"},{"key":"R53-10-20210128","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jcv.2004.08.005","article-title":"Comparison of hepatitis C virusRNA detection in plasma, whole blood and peripheral blood mononuclear cells of patients with occult hepatitis C virus infection","volume":"31","author":"Carreno","year":"2004","journal-title":"J Clin Virol"},{"key":"R54-10-20210128","first-page":"316","article-title":"Hepatitis C virus infection and arthritis: a clinico-serological investigation of arthritis in patients with or without cryoglobulinemic syndrome","volume":"54","author":"Fadda","year":"2002","journal-title":"Reumatismo"},{"key":"R55-10-20210128","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1002\/art.20355","article-title":"Absence of antibodies to cyclic citrullinated peptide in sera of patients with hepatitis C virus infection and cryoglobulinemia","volume":"50","author":"Wener","year":"2004","journal-title":"Arthritis-Rheum"},{"key":"R56-10-20210128","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1212\/01.WNL.0000137017.45065.3E","article-title":"Sensory neuropathy in vasculitis: a clinical, pathologic, and electrophysiologic study","volume":"63","author":"Seo","year":"2004","journal-title":"Neurology"},{"key":"R57-10-20210128","first-page":"484","article-title":"Central nervous system involvement in hepatitis C virus cryoglobulinemia vasculitis: a multicenter case-control study using magnetic resonance imaging and neuropsychological tests","volume":"32","author":"Casato","year":"2005","journal-title":"J Rheumatol"},{"key":"R58-10-20210128","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1055\/s-2005-864787","article-title":"The nervous system and hepatitis C virus","volume":"25","author":"Morgello","year":"2005","journal-title":"Semin Liver Dis"},{"key":"R59-10-20210128","doi-asserted-by":"crossref","first-page":"144","DOI":"10.5414\/CNP61144","article-title":"Membranous glomerulonephritis associated with hepatitis C virus infection: case report and literature review","volume":"61","author":"Uchiyama Tanaka","year":"2004","journal-title":"Clin Nephrol"},{"key":"R60-10-20210128","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1093\/rheumatology\/keh011","article-title":"Type 2 diabetes in hepatitis C-related mixed cryoglobulinaemia patients","volume":"43","author":"Antonelli","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"R61-10-20210128","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.288.6.698","article-title":"Erectile dysfunction and HCV infection","volume":"14","author":"Ferri","year":"2002","journal-title":"JAMA"},{"key":"R62-10-20210128","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000205684","article-title":"Essential mixed cryoglobulinemia, type II: a manifestation of low malignant lymphoma? Clinical-morphological study of 12 cases with special reference to immunohistochemical findings in liver frozen sections","volume":"79","author":"Monteverde","year":"1988","journal-title":"Acta Haematol"},{"key":"R63-10-20210128","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1001\/archinte.165.1.101","article-title":"Incidence and characteristics of non-Hodgkin lymphomas in a multicenter case file of patients with hepatitis C virus-related symptomatic mixed cryoglobulinemias","volume":"165","author":"Monti","year":"2005","journal-title":"Arch Intern Med"},{"key":"R64-10-20210128","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1182\/blood-2004-05-1711","article-title":"Splenic lymphoma with villous lymphocytes, associated with type II cryoglobulinemia and HCV infection: a new entity?","volume":"105","author":"Saadoun","year":"2005","journal-title":"Blood"},{"key":"R65-10-20210128","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1365-2796.1994.tb01116.x","article-title":"Hepatitis C virus as common cause of mixed cryoglobulinemia and chronic liver disease","volume":"236","author":"Ferri","year":"1994","journal-title":"J Intern Med"},{"issue":"6 Suppl 32","key":"R66-10-20210128","first-page":"S89","article-title":"Prevalence of ANCA in mixed cryoglobulinemia and chronic hepatitis C virus infection","volume":"21","author":"Lamprecht","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"R67-10-20210128","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","article-title":"Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group","volume":"61","author":"Vitali","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"R68-10-20210128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-200101000-00001","article-title":"Hepatitis c virus infection mimicking primary Sjogren's syndrome: a clinical and immunologic description of 35 cases","volume":"80","author":"Ramos-Casals","year":"2001","journal-title":"Medicine (Baltimore)"},{"key":"R69-10-20210128","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/art.10221","article-title":"Long term risk of mortality and lymphoproliferative disease and predictive classification of primary Sj\u00f6gren's syndrome","volume":"46","author":"Ioannidis","year":"2002","journal-title":"Arth Rheum"},{"key":"R70-10-20210128","first-page":"61","article-title":"Prognostic implications of mixed monoclonal cryoglobulinemia in Sjogren's disease","volume":"76","author":"Vasil'ev","year":"2004","journal-title":"Ter Arkh"},{"key":"R71-10-20210128","first-page":"143","article-title":"Outcome measures for Sjogrens syndrome, april 10-11, 2003. Bethesda, Maryland, USA.","volume":"31","author":"Pillemer","year":"2004","journal-title":"J Rheumatol"},{"key":"R72-10-20210128","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/rheumatology\/keh407","article-title":"Hypocomplementaemia as an immunological marker of morbidity and mortality in patients with primary Sjogren's syndrome","volume":"44","author":"Ramos-Casals","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"R73-10-20210128","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.autrev.2004.04.004","article-title":"Hepatitis C virus, Sjogren's syndrome and B-cell lymphoma: linking infection, autoimmunity and cancer","volume":"4","author":"Ramos-Casals","year":"2005","journal-title":"Autoimmun Rev"},{"key":"R74-10-20210128","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/01.md.0000157397.30055.c9","article-title":"Sjogren syndrome associated with hepatitis C virus: a multicenter analysis of 137 cases","volume":"84","author":"Ramos-Casals","year":"2005","journal-title":"Medicine"},{"key":"R75-10-20210128","first-page":"1473","article-title":"Hepatitis C virus infection in systemic lupus erythematosus: a case-control study","volume":"30","author":"Perlemuter","year":"2003","journal-title":"J Rheumatol"},{"key":"R76-10-20210128","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00002281-200007000-00011","article-title":"Hepatitis C-associated arthritis","volume":"12","author":"Buskila","year":"2000","journal-title":"Curr Opin Rheumatol"},{"key":"R77-10-20210128","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000206699","article-title":"Secondary and essential cryoglobulinemias: frequency, nosological classification, and long-term follow-up","volume":"70","author":"Invernizzi","year":"1983","journal-title":"Acta Haematol"},{"key":"R78-10-20210128","first-page":"2199","article-title":"Long term course of mixed cryoglobulinemia in patients infected with hepatitis C virus","volume":"31","author":"Sene","year":"2004","journal-title":"Rheumatology"},{"issue":"Suppl 32","key":"R79-10-20210128","first-page":"S78","article-title":"HCV-related cryoglobulinemic vasculitis: an update on its etiopathogenesis and therapeutic strategies","volume":"21","author":"Ferri","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"R80-10-20210128","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1002\/(SICI)1097-0142(19960615)77:12<2604::AID-CNCR26>3.0.CO;2-V","article-title":"Regression of monoclonal B-cell expansion in patients affected by mixed cryoglobulinemia responsive to \u03b1-interferon therapy","volume":"77","author":"Mazzaro","year":"1996","journal-title":"Cancer"},{"key":"R81-10-20210128","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1182\/blood-2002-05-1537","article-title":"Effect of antiviral treatment in patients with chronic HCV infection and t[14;18) translocation","volume":"102","author":"Giannelli","year":"2003","journal-title":"Blood"},{"key":"R82-10-20210128","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1053\/j.ajkd.2003.11.020","article-title":"Influence of antiviral therapy in hepatitis C virus-associated cryoglobulinemic MPGN","volume":"43","author":"Alric","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"R83-10-20210128","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/art.20958","article-title":"PEGylated Interferon Alfa-2b and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis","volume":"52","author":"Cacoub","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R84-10-20210128","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jhep.2004.10.031","article-title":"Treatment with peg-interferon alfa-2b and ribavirin of hepatitis C virus-associated mixed cryoglobulinemia: a pilot study","volume":"42","author":"Mazzaro","year":"2005","journal-title":"J Hepatol"},{"key":"R85-10-20210128","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/mus.20184","article-title":"Peripheral neuropathy in hepatitis-related mixed cryoglobulinemia: electrophysiologic follow-up study","volume":"31","author":"Ammendola","year":"2005","journal-title":"Muscle Nerve"},{"key":"R86-10-20210128","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s10067-004-1024-2","article-title":"Systemic lupus erythematosus arising during interferon-alpha therapy for cryoglobulinemic vasculitis associated with hepatitis C","volume":"24","author":"Niewold","year":"2005","journal-title":"Clin Rheumatol"},{"key":"R87-10-20210128","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1097\/01.meg.0000108342.41221.0c","article-title":"Sustained exacerbation of cryoglobulinaemia-related vasculitis following treatment of hepatitis C with peginterferon alfa","volume":"16","author":"Batisse","year":"2004","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R89-10-20210128","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1056\/NEJM199805073381914","article-title":"Interferon for hepatitis C virus-negative type II mixed cryoglobulinemia","volume":"338","author":"Casato","year":"1998","journal-title":"N Engl J Med"},{"key":"R91-10-20210128","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1182\/blood-2002-09-2856","article-title":"Efficacy and safety of rituximab in type II mixed cryoglobulinemia","volume":"101","author":"Zaja","year":"2003","journal-title":"Blood"},{"key":"R92-10-20210128","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.1182\/blood-2002-10-3162","article-title":"Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon alpha with an anti-CD20","volume":"101","author":"Sansonno","year":"2003","journal-title":"Blood"},{"key":"R93-10-20210128","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1093\/ndt\/gfh469","article-title":"Long-term effects of anti-CD20 monoclonal antibody treatment of cryoglobulinaemic glomerulonephritis","volume":"19","author":"Roccatello","year":"2004","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl III","key":"R94-10-20210128","first-page":"539","article-title":"Rituximab in HCV-related mixed cryoglobulinemia: report of 4 cases [abstract]","volume":"64","author":"Migliaresi","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"R95-10-20210128","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1136\/ard.2002.004929","article-title":"Rituximab induces remission in refractory HCV associate cryoglobulinaemic vasculitis","volume":"62","author":"Lamprecht","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"R96-10-20210128","first-page":"1164","article-title":"Persistent cryoglobulinemic vasculitis following successful treatment of hepatitis C virus","volume":"32","author":"Levine","year":"2005","journal-title":"J Rheumatol"},{"key":"R97-10-20210128","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s00277-005-1053-1","article-title":"Successful management of cryoglobulinemia-induced leukocytoclastic vasculitis with thalidomide in a patient with multiple myeloma","volume":"84","author":"Cem Ar","year":"2005","journal-title":"Ann Hematol"},{"key":"R98-10-20210128","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/ndt\/gfh564","article-title":"Remission of refractory hepatitis C-negative cryoglobulinaemic vasculitis after rituximab and infliximab","volume":"20","author":"Koukoulaki","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"R99-10-20210128","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1093\/rheumatology\/keh080","article-title":"Infliximab in the treatment of refractory vasculitis secondary to hepatitis C-associated mixed cryoglobulinaemia","volume":"43","author":"Chandesris","year":"2004","journal-title":"Rheumatology (Oxford)"},{"issue":"Suppl 2","key":"R100-10-20210128","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/ard.2004.028209","article-title":"Safety of antitumour necrosis factor (anti-TNF) therapy in patients with chronic viral infections: hepatitis C, hepatitis B, and HIV infection","volume":"63","author":"Calabrese","year":"2004","journal-title":"Ann Rheum Dis"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00005110-201204000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T12:35:30Z","timestamp":1736166930000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002281-200601000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":96,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1097\/01.bor.0000198002.42826.c2","relation":{},"ISSN":["1040-8711"],"issn-type":[{"value":"1040-8711","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1]]}}}